MULPLETA Trademark

Trademark Overview


On Monday, December 22, 2014, a trademark application was filed for MULPLETA with the United States Patent and Trademark Office. The USPTO has given the MULPLETA trademark a serial number of 79163223. The federal status of this trademark filing is Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, May 25, 2022. This trademark is owned by SHIONOGI & CO., LTD.. The MULPLETA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders, urological disorders, sexual dysfunction, HIV and AIDS, central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, viral disorders, fungal disorders, infectious diseases, inflammation and inflammatory diseases, sepsis, immunological disorders, musculoskeletal disorders, disease and disorders of the liver, allergic rhinitis, and opioid-induced constipation; pharmaceutical preparations for treating thrombocytopenia
mulpleta

General Information


Serial Number79163223
Word MarkMULPLETA
Filing DateMonday, December 22, 2014
Status739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, May 25, 2022
Registration Number4890938
Registration DateTuesday, January 26, 2016
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, November 10, 2015

Trademark Statements


Description of MarkThe mark consists of the wording "MULPLETA" in a stylized font.
Goods and ServicesPharmaceutical preparations for the treatment and prevention of cardiovascular diseases, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders, urological disorders, sexual dysfunction, HIV and AIDS, central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, viral disorders, fungal disorders, infectious diseases, inflammation and inflammatory diseases, sepsis, immunological disorders, musculoskeletal disorders, disease and disorders of the liver, allergic rhinitis, and opioid-induced constipation; pharmaceutical preparations for treating thrombocytopenia
Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe word(s) "MULPLETA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 15, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEDDINGPHARM (HONG KONG) COMPANY LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type24 - NOT AVAILABLE
AddressCN

Party NameSHIONOGI & CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressOsaka-shi; Osaka 541-0045
JP

Party NameSHIONOGI & CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameSHIONOGI & CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Wednesday, April 15, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 9, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, April 13, 2015LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, September 24, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 15, 2015ASSIGNED TO EXAMINER
Thursday, April 16, 2015NON-FINAL ACTION WRITTEN
Friday, April 17, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, April 17, 2015REFUSAL PROCESSED BY MPU
Friday, April 17, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, April 21, 2015APPLICATION FILING RECEIPT MAILED
Friday, May 8, 2015REFUSAL PROCESSED BY IB
Tuesday, September 1, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 17, 2015ASSIGNED TO LIE
Thursday, September 24, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 26, 2016REGISTERED-PRINCIPAL REGISTER
Monday, September 28, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 5, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 21, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 4, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 4, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, November 10, 2015PUBLISHED FOR OPPOSITION
Tuesday, November 10, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, November 20, 2015NOTIFICATION PROCESSED BY IB
Tuesday, April 26, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, April 28, 2016FINAL DISPOSITION PROCESSED
Thursday, April 28, 2016FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 13, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, January 26, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Wednesday, November 10, 2021TEAS SECTION 71 & 15 RECEIVED
Wednesday, May 25, 2022NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Monday, May 23, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 25, 2022REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Thursday, October 17, 2024CHANGE OF OWNER RECEIVED FROM IB
Sunday, January 26, 2025COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Thursday, October 24, 2024INTERNATIONAL REGISTRATION RENEWED